• Blog
  • Getting Uncomfortable With Esketamine
Previous Post
Episode
Next Post
Episode

Getting Uncomfortable With Esketamine

The Carlat Psychiatry Blog, Volume , Number ,
https://www.thecarlatreport.com///

From The Carlat Psychiatry Blog, ,
Print Friendly, PDF & Email

Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety. We interview Dr. Nolan Williams from Stanford University about these issues and where esketamine fits in our interventions for treatment resistant depression.
Date Published: 1/13/2020

Duration: 12 minutes, 21 seconds

Take the Podcast Survey to help us launch a CME option in 2020.

Suggested Articles

Powered by Contextual Related Posts

Comments